Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Neurofilaments May Be Essential to Some Tauopathies
14 August 2001. It appears that some tauopathies require the presence of neurofilaments for neurodegeneration to occur. In the 15 August Journal of Neuroscience, Virginia Lee, Takeshi Ishihara, and colleagues at the University of Pennsylvania describe how they were able to reduce dramatically the number of intraneuronal tau aggregates-as well as reduce disease symptoms-in their tau transgenic mice by crossing them with knockout mice lacking particular neurofilament subunits.

Neurofilaments are found in neuropathologic lesions in a number of the tauopathies (e.g., neurofibrillary tangles in Alzheimer's disease; Lewy bodies in Parkinson's disease; axonal spheroids in amyotrophic lateral sclerosis/parkinsonism-dementia complex [ALS/PDC]), but their role in these diseases is unclear. In Alzheimer's, for example, neurofilaments do not appear in tangles until very late in the disease, suggesting that they may have no pathogenic role. On the other hand, neurofilaments are an early and significant component of the tau-containing inclusions found in spinal cord motor neurons in classic ALS, ALS/PDC, and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17).

The Lee group's mouse model recapitulates some of the features of FTDP-17 and ALS/PDC, including tau-containing intraneuronal aggregates in spinal cord motor neurons. Because these inclusions contain neurofilaments, the researchers decided to crossbreed the mice with others that lacked neurofilament subunits L or H (NFL, NFH). Especially in the mice lacking NFL, Lee's group found dramatic reductions in the numbers of tau aggregates in spinal cord and brainstem neurons. The mice deficient in neurofilaments also lived longer, weighed more, and suffered less limb weakness than did the standard tau transgenic mice.

The results suggest that neurofilaments are essential for the formation and pathogenicity of at least some tau aggregates. Interestingly, Lee's group has found that the tau transgenic mice develop neurofilament-negative tau inclusions in the hippocampus and associated areas as they age, similar to the tangles found in normal aging in humans. In this study, the absence of neurofilament did not prevent the formation of hippocampal neuron inclusions, suggesting to the authors that they have identified two separate mechanisms for the formation of tau inclusions, one that is neurofilament-dependent and one that is neurofilament-independent.-Hakon Heimer.

Reference:Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, Trojanowski JQ, Lee VM. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci. 2001 Aug 15;21(16):6026-35. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad